These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7932316)

  • 1. Hepatic lipocytes, TIMP-1 and liver fibrosis.
    Arthur MJ; Iredale JP
    J R Coll Physicians Lond; 1994; 28(3):200-8. PubMed ID: 7932316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of matrix proteins in liver fibrosis.
    Arthur MJ
    Pathol Res Pract; 1994 Oct; 190(9-10):825-33. PubMed ID: 7899131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagenases and liver fibrosis.
    Arthur MJ
    J Hepatol; 1995; 22(2 Suppl):43-8. PubMed ID: 7665849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitors of metalloproteinases in liver fibrosis.
    Iredale JP
    Int J Biochem Cell Biol; 1997 Jan; 29(1):43-54. PubMed ID: 9076940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver.
    Iredale JP; Murphy G; Hembry RM; Friedman SL; Arthur MJ
    J Clin Invest; 1992 Jul; 90(1):282-7. PubMed ID: 1634616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.
    Benyon RC; Iredale JP; Goddard S; Winwood PJ; Arthur MJ
    Gastroenterology; 1996 Mar; 110(3):821-31. PubMed ID: 8608892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
    Rockey DC; Chung JJ
    J Investig Med; 1994 Dec; 42(4):660-70. PubMed ID: 8521029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.
    Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
    Biomed Pharmacother; 2023 May; 161():114472. PubMed ID: 37002573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.
    Herbst H; Wege T; Milani S; Pellegrini G; Orzechowski HD; Bechstein WO; Neuhaus P; Gressner AM; Schuppan D
    Am J Pathol; 1997 May; 150(5):1647-59. PubMed ID: 9137090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrogenesis and fibrolysis in the liver].
    Herbst H; Schuppan D; Milani S
    Verh Dtsch Ges Pathol; 1995; 79():15-27. PubMed ID: 8600680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alcoholic liver cirrhosis].
    Ishii H; Arai M
    Nihon Rinsho; 1994 Jan; 52(1):19-26. PubMed ID: 8114291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease.
    Arthur MJ; Iredale JP; Mann DA
    Alcohol Clin Exp Res; 1999 May; 23(5):940-3. PubMed ID: 10371419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is liver fibrosis reversible?
    Benyon RC; Iredale JP
    Gut; 2000 Apr; 46(4):443-6. PubMed ID: 10716665
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes.
    Iredale JP; Goddard S; Murphy G; Benyon RC; Arthur MJ
    Clin Sci (Lond); 1995 Jul; 89(1):75-81. PubMed ID: 7671571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies.
    Reynolds JJ; Meikle MC
    J R Coll Surg Edinb; 1997 Jun; 42(3):154-60. PubMed ID: 9195805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.
    Arthur MJ; Mann DA; Iredale JP
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S33-8. PubMed ID: 9792032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix degradation and the role of hepatic stellate cells.
    Benyon RC; Arthur MJ
    Semin Liver Dis; 2001 Aug; 21(3):373-84. PubMed ID: 11586466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases.
    McCrudden R; Iredale JP
    Histol Histopathol; 2000 Oct; 15(4):1159-68. PubMed ID: 11005241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Ito cells in the degradation of matrix in liver.
    Arthur MJ
    J Gastroenterol Hepatol; 1995; 10 Suppl 1():S57-62. PubMed ID: 8589345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
    Arthur MJ
    Am J Physiol Gastrointest Liver Physiol; 2000 Aug; 279(2):G245-9. PubMed ID: 10915630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.